← Back to Search

Dietary Supplement

UTI Prophylaxis With Cranberry Extract After Female Incontinence Surgery

N/A
Waitlist Available
Led By Lieschen Quiroz, MD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks

Summary

This trial is testing whether cranberry extract pills can prevent urinary tract infections in women after incontinence surgery. The cranberry extract contains a substance that may stop bacteria from sticking to the urinary tract, potentially preventing infections. Cranberry extract has been studied for its potential to reduce urinary tract infections, including in individuals with neurogenic bladders and those undergoing prolapse surgery.

Eligible Conditions
  • Urinary Tract Infection
  • Bladder control issues

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Urine culture based on type of symptoms
Secondary study objectives
Duration of symptoms

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Cranberry Extract CapsulesExperimental Treatment1 Intervention
36mg of proanthocyanidins in cranberry capsules
Group II: Placebo CapsulesPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cranberry extract capsules
2021
N/A
~180

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
473 Previous Clinical Trials
93,540 Total Patients Enrolled
Lieschen Quiroz, MDPrincipal InvestigatorUniversity of Oklahoma
4 Previous Clinical Trials
232 Total Patients Enrolled
~21 spots leftby Dec 2025